Welcome to Pronai.investorroom.com - Sierra Oncology, Inc.

pronai.investorroom.com

Description: Pronai Investor Room. Investor Relations...

Google PR 0

Trustworthiness Unknown
Avg. Daily Visitors N/A

Child Safety Unknown
Avg. Daily Pageviews N/A

Privacy Unknown

Sierra Oncology, Inc. - Investor Relations

Pronai.investorroom.com: get to the top rated Pronai Investor Room pages and content popular with India-based Pronai.investorroom.com users or check the following digest to find out more. Pronai.investorroom.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Pronai.investorroom.com team has yet to grow their social media activity, as the major social networks contain little or no materials related to this domain. Pronai.investorroom.com is hosted with CloudFlare, Inc. in United States. Pronai Investor Room traffic is not yet estimated by Alexa.

Visit pronai.investorroom.com

Domain info

Location:	United States
Registrant:	Not Disclosed Not Disclosed (Not Disclosed)
Hosted by:	CloudFlare, Inc.
Registrar:	CSC Corporate Domains, Inc.
Subnetworks:	104.17.202.159, 104.17.203.159, 104.17.204.159, 104.17.205.159, 104.17.206.159

Social Media Activities

Facebook likes: -
Twitter mentions: -
Google pluses: -
LinkedIn mentions: -
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Pronai.investorroom.com popular pages to visit

ProNAi Therapeutics, Inc. Investors - Presentations Presentations Vancouver, BC V6C 3E8

ProNAi Therapeutics, Inc. Investors - Events and Webcasts Browse the calendar to view Investor related events and announcements. Webcasts and presentations that have been archived are available by viewing historical event details.

ProNAi to Present at JP Morgan 34th Annual Healthcare Conference in San Francisco - Dec 22, 2015 ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform, today announced that Dr....